Vaccine Optimism Boosts Stocks, NFP Up Next

An injection of optimism from vaccine news has spurred stocks higher, attention will now turn to the US labour market

Uptrend 3

An injection of optimism from vaccine news has spurred stocks higher. Asian markets advanced overnight with the upbeat mood spilling into Europe for the open. Bourses in Europe are pointing to a stronger start, paring losses from the previous session.

Vaccine news has been in short supply over recent weeks. News that a vaccine from Pfizer and Germany’s BioNTech produced a strong immune response and is being well tolerated in early stage human trials has been well received. Particularly as the number of coronavirus cases top 10.5 million globally and the cases in the US are increasing at a daily rate of around 50,000 a day, whilst reopening measures are being halted.

Hong Kong & Brexit concerns pushed aside for now
Investors are doing a good job at shrugging off other market woes, including the arrest of 300 protesting in Hong Kong following the introduction of sweeping Chinese laws to control dissent. The latest developments will raise concerns over already strained relations between China and the rest of the western world.

In the UK, the mood remains upbeat with both the Pound advancing and the FTSE set to open higher, despite growing doubts over whether a post Brexit trade deal will be reached. Angela Merkel confirmed that progress in talks had been minimal and that the EU must prepare for the prospect of a deal not being reached. This would see the UK leave the EU on unfavourable World Trade Organisation rules.

The NFP test
Attention will now turn towards the keenly awaited US jobs report which will shed light on whether the US is able to sustain its fragile economic recovery even as covid-19 numbers surge across the south of the country.

Expectations are for 3 million jobs to have been created in June, following an unexpected increase of 2.5 million in May, whilst extending the recovery from 20 million lost in April. The unemployment rate is expected to tick lower to 12.3% from 13.3%. Wage growth is expected to remain elevated as mainly low wage employees lost their jobs

Yesterday’s ADP payroll report revealed a disappointing, albeit record, 2.3 million private payrolls added in June when 3 million had ben forecast. Given the strong correlation between ADP payrolls and NFP’s there is a good chance that we could be in for a disappointing print today. That said, NFP has a tendency to surprise and data recently has been anything but predictable given the rapid nature of developments and possible errors in classification.

As reopening plans are put on pause or are being rolled back in areas of the US, a weak report could refocus market fears and drag stocks lower whilst boost the safe haven US Dollar. On the other hand, a strong report, combined with vaccine optimism could see stocks surge towards the weekend.

FTSE Chart

More from FTSE 100

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.

Open an Account